Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Treatment Options in Oncology|February 14, 2012
Parathyroid carcinoma: update and guidelines for managementChristina H Wei, Avital HarariFrontiers in Oncology|February 14, 2024
Ovarian steroid cell tumors: what do we know so far?Christina H Wei, Oluwole FadareArchives of Pathology & Laboratory Medicine|October 28, 2020
Quantitative Impact of the 2018 American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Practice Guideline Update on Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: A Systematic AnalysisChristina H Wei, Lino Garcia, Joyce Murata-Collins, et al.International Journal of Surgical Pathology|April 25, 2022
Outcome for Neoadjuvant Treatment of Parotid Gland Adamantinoma-Like Ewing Sarcoma: Case Report and Review of LiteraturesChristina H Wei, Lester D R Thompson, Kyle Lee, et al.Experimental and Molecular Pathology|August 23, 2015
Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapyChristina H Wei, Andrew Penunuri, George Karpouzas, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2018
Evaluation of Cyclin D1 as a Discriminatory Immunohistochemical Biomarker for Idiopathic Pulmonary FibrosisChristina H Wei, Felicita E Baratelli, Guang-Qian Xiao, et al.Annals of Diagnostic Pathology|November 20, 2024
Poor response of HER2-positive mucinous carcinomas of breast to neoadjuvant HER2-targeted therapy: A study of four casesMin Han, Daniel Schmolze, Javier A Arias-Stella, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 19, 2023
SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic MalignanciesChristina H Wei, Evita Sadimin, Mark Agulnik, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|December 28, 2016
Gain of TP53 Mutation in Imatinib-treated SDH-Deficient Gastrointestinal Stromal Tumor and Clinical Utilization of Targeted Next-generation Sequencing Panel for Therapeutic Decision SupportChristina H Wei, Jonas Pettersson, Mihaela Campan, et al.Pancreas|October 25, 2013
A meta-analysis of gemcitabine biomarkers in patients with pancreaticobiliary cancersChristina H Wei, Tristan R Gorgan, David A Elashoff, et al.Pageof 2